Interest of Daily Physical Activity After Cancer Treatment

Cancer Clinical Trial

— APQ  

Official title:

Evaluation du Niveau d'activité Physique Quotidien, Chez Des Patientes Porteuses d'un Cancer du Sein en période Post thérapeutique

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02013921
• Other study ID #: I12040
• Status: Completed
• Start date: December 2013
• Est. completion date: December 2015

Study information

• Verified date: April 2015
• Source: University Hospital, Limoges
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Many studies have demonstrated the beneficial effects of Adapted Physical Activity (APA) in different cancer types.

It therefore seems necessary to assess spontaneous Physical Activity in order to integrate it to the overall calculation of physical activity in clinical practice.

To assess the AP, two types of methods are validated : the subjective method using a questionnaries and objective method using a pedometer , accelerometer or measures calorimetry .

Subjective method shows , good acceptability by patients and low cost but can sometimes lead to poor estimation of the level of activity.

Objective methods obviously increase the accuracy of assessments but are more difficult to use for epidemiological studies , less accepted by the patient and more expensive.

In this study the investigators will measure the spontaneous Daily Physical Activity by both methods andd evaluate the correclation.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 31
• Est. completion date: December 2015
• Est. primary completion date: December 2015
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• adult (age = 18 years)

• Having been informed of the study orally and in writing and have not expressed opposition to his participation

• Performance status <2

• Invasive breast adenocarcinoma, histologically documented.

• Patients with a breast cancer and are completing treatment

• Exclusion Criteria:

• Patient with metastatic cancer.

• Patient for which monitoring required by the protocol is impossible.

Related Conditions & MeSH terms

• Cancer
• Tiredness

Intervention

Other:
• Physical activity

Locations

Country	Name	City	State
France	Oncologie- CHU Limoges	Limoges

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Limoges

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Daily physical activity assessment at 3 months	Physical activity is measured by means of an Actigraph. Patients will measure their daily physical activity , three times during one week espaced by 1 month.	Month 3